Weight management · 5 min read · Evidence-informed guide
GLP-1 Weight-Loss Medicines: Questions to Ask
FDA-approved medicines such as Wegovy (semaglutide) and Zepbound (tirzepatide) have specific approved uses. Whether a medicine is appropriate depends on your medical history, current medicines, risks, goals, and access—not an online eligibility quiz.
Key answer
The short version
FDA-approved medicines such as Wegovy (semaglutide) and Zepbound (tirzepatide) have specific approved uses. Whether a medicine is appropriate depends on your medical history, current medicines, risks, goals, and access—not an online eligibility quiz.
Use the exact medication name
Semaglutide and tirzepatide are generic names; brands can have different FDA-approved indications. FDA identifies Wegovy for obesity or overweight and Zepbound for chronic weight management in qualifying adults, alongside reduced-calorie nutrition and physical activity.
A safe medication conversation
Discuss your health history, current medicines, pregnancy plans where relevant, possible side effects, cost and coverage, and follow-up. Do not start, stop, or change a prescription medicine based on a blog post.
Be careful with unapproved versions
FDA warns that unapproved versions of GLP-1 drugs do not undergo its review for safety, effectiveness, and quality. Use a prescription from your clinician and a state-licensed pharmacy, and ask questions about the product and instructions you receive.
Clinical perspective
How to think about this
Prescription weight management is longitudinal medical care, not a consumer transaction. A sound plan weighs approved use, safety, nutrition, access, follow-up, and the patient’s own goals; it should never reduce a complex health decision to a promised outcome or a single number on a scale.
Questions worth bringing to a visit
- What FDA-approved option, if any, fits my clinical situation?
- What safety monitoring and follow-up would I need?
- How will we assess benefit, tolerability, and access over time?
Continue exploring
Related patient questions
Sources
1. FDA, Concerns with Unapproved GLP-1 Drugs Used for Weight Loss
Current safety guidance on unapproved GLP-1 products.
2. FDA, Zepbound approval for chronic weight management
Approved-use context and common adverse effects.